Life Science News

10 December 2002 - Diosynth to acquire GSK's Scottish pharma manufacturing site

Deal completion in 2003 ’will increase Akzo Nobel’s production capacity for pharmaceutical ingredients’ Diosynth, the manufacturing business of Akzo..  More >>

09 December 2002 - Pharmacia approves of merger with Pfizer

Pharmacia Corp shareholders at a special meeting approved its proposed merger with Pfizer Inc. About 71% of outstanding shares, and 99% of the total votes..  More >>

09 December 2002 - Novo Nordisk seeks US approval for long-acting Insulin

Denmark’s Novo Nordisk has filed a request with the US FDA for authorization of its long-acting insulin analogue, NN304. Novo Nordisk, which hopes to obtain..  More >>

09 December 2002 - Pfizer Shareholders approve Pharmacia purchase

Issue of new shares approved to fund purchase while Pharmacia shareholders meet to decide on the bid Pfizer’s shareholders approved the purchase of Pharmacia..  More >>

09 December 2002 - Scientific Research in France

Scientific Research: "Claudie Haigneré takes on the private financing initiative" Les Echos, in their Sciences column, looks at..  More >>

06 December 2002 - Pfizer - Pharmacia merger on track for early 2003

Pfizer and Pharmacia report ’encouraging progress’ with plans. Pfizer and Pharmacia announced "encouraging progress" in discussions with the..  More >>

05 December 2002 - Aventis Pasteur announces major investment in vaccines

Major Vaccine initiative by Aventis Pasteur The France based journal, ’La Tribune’, today devoted a full page to investments envisaged by Aventis Pasteur in..  More >>

04 December 2002 - Celltech boss elected to Chair British Biotech

British Biotech appoints new Chairman Dr Peter Fellner was today elected to the Board of Directors of British Biotech, and will be appointed non-executive..  More >>

04 December 2002 - Evotec OAI in collaboration with Prolysis for antibiotics

Biology and chemistry discovery and development agreement ’worth €5 million’ Hamburg, Germany based Evotec OAI AG with an office in Oxford, UK and..  More >>

04 December 2002 - Giliad to acquire Triangle

Gilead Sciences deal to Acquire Triangle Pharmaceuticals worth $464 million Plan involves a two-step acquisition whereby Triangle will become a wholly..  More >>

04 December 2002 - Syngenta and Diversa in biopharma R&D deal

Syngenta and Diversa form R & D alliance Discovery activities in genomics combine for new plant science applications in selected antibody generation and..  More >>

03 December 2002 - Ukraine's plant biopharma deal with biotechs in USA and Germany

  Ukraine to develop biopharmaceuticals in living plants ’for regional needs’ The government of Ukraine seeks to bring down the overall cost and..  More >>